USPTO trademark

UPSENDLI

RegisteredUSPTOWord markClass 5

"UPSENDLI" is a word mark owned by Glaxo Group Limited, filed at the USPTO on March 27, 2025. It is registered and covers class 5 (Pharmaceuticals).

View Glaxo Group Limited portfolio Get this data via the API

Data current as of December 23, 2025Official USPTO record

As filed with the USPTO

Status: Registered; Since December 23, 2025
Filed: March 27, 2025
Registered: December 23, 2025
Priority date: February 7, 2025; Claimed from United Kingdom
Application no.: 99106858
Registration no.: 8075627
Office: USPTO; United States Patent and Trademark Office
Mark type: Word mark; 1 class

Ownership

Who owns UPSENDLI

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Glaxo Group Limited

Stevenage, United Kingdom

19,383 trademarks in the portfolioView company

Representative

Christopher M. Hanes

GSK

Goods and services

What the mark covers

The products and services UPSENDLI is filed for, grouped by Nice class.

05Class 5 · Pharmaceuticals
Vaccines; Anti-infectives; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases

History

What has happened so far

Steps recorded by the USPTO, newest first.

December 23, 2025Notice of registration confirmation emailed
December 23, 2025Registered-principal register
November 4, 2025Official gazette publication confirmation e-mailed
November 4, 2025Published for opposition
October 29, 2025Notification of notice of publication e-mailed
October 1, 2025Approved for pub - principal register
September 11, 2025Teas/email correspondence entered
September 11, 2025Correspondence received in law office
September 11, 2025Teas response to suspension inquiry received
August 28, 2025Notification of letter of suspension e-mailed

6 earlier steps on the official record.

FAQ

About UPSENDLI

Who owns the trademark "UPSENDLI"?

The USPTO trademark "UPSENDLI" (application 99106858) is owned by Glaxo Group Limited.

What is the status of "UPSENDLI"?

Its status at the USPTO is: registered.

When was "UPSENDLI" registered?

It was registered on December 23, 2025.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull UPSENDLI and marks like it into your own product with one request.

GET/v1/trademarks/{id}
The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/events
Every step in the office history
GET/v1/proceedings?trademark_id={id}
Oppositions and cancellations against the mark

Get API key View docs

GET /v1/trademarks/{id}

ID=tm_019d2a9b-0467-713e-a0e2-2c4af4ae9f25
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "id": "tm_019d2a9b-0467-713e-a0e2-2c4af4ae9f25",
  "object": "trademark",
  "mark_text": "UPSENDLI",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "99106858",
  "filing_date": "2025-03-27",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Glaxo Group Limited",
      "entity_id": "ent_019eb6f6-4cb9-77ae-916f-63b3231a6d3d"
    }
  ]
}